Register for this event

"*" indicates required fields

Southern Star Research values your privacy and is committed to protecting your personal information. We’ll only use your details for essential communications related to your account. From time to time, we’d like to share updates about our latest news, research, and other content that may interest you.

Our expert attending

Dedicated professionals committed to clinical excellence.

Meet Daniel Evans on the US West Coast

Daniel Evans, Director of Business Development at Southern Star Research, is relocating to the US West Coast, where he will be based from November 2026 through 2027.

Daniel will be connecting with biotech and pharmaceutical companies, clinical development leaders and industry partners across the region, building relationships and exploring opportunities for collaboration.

As part of his engagements, Daniel will also be attending COG: Small and Mid BioPharma Summit on 18–19 November 2026 in Burlingame, California, providing an opportunity to connect with industry peers and clinical development leaders.

For US-based sponsors considering clinical development in Australia and across Asia Pacific, Daniel welcomes the opportunity to discuss upcoming programs, clinical trial strategies and potential partnerships.

How We Accelerate Your Clinical Development

  • Proactive Partnership: We commit to engaging intellectually and energetically with our clients’ challenges. Our teams apply foresight, critical thinking and domain expertise to anticipate obstacles and contribute meaningfully to the trial’s success.
  • Embedded Quality: We define quality not just by compliance, but by the consistent application of judgment, rigour and thoughtful planning throughout all stages of the clinical trial process.
  • Tailored Execution: Our flexible, hands-on approach means your study is designed for both scientific and commercial success, tailored to your strategy, timelines and endpoints.

As a mid-sized CRO with strong early-phase capabilities, Southern Star Research supports first-in-human, first-in-patient and Phase I–II clinical trials, as well as later-phase development.

Our focus is on generating high-quality data that meets international regulatory expectations and supports confident decisions as programs progress towards later-stage development, partnerships, licensing and future investment.

Connect with Daniel

Whether you’re planning an upcoming clinical trial, exploring Australia and Asia Pacific for clinical development, or looking to establish new industry connections, Daniel welcomes the opportunity to meet.

Interested in connecting? Request a meeting with Daniel to discuss your clinical development plans or explore opportunities for collaboration.